Results 1 to 2 of 2

Thread: Joslin And Stanford Researchers Find Key Clues To Muscle Regeneration

  1. #1
    Senior Member giambjj's Avatar
    Join Date
    Jul 2001
    Location
    Auburn, AL,USA
    Posts
    1,866

    Joslin And Stanford Researchers Find Key Clues To Muscle Regeneration

    Scientists at Stanford University and Joslin Diabetes Center are providing new insights into how muscle cells regenerate -- leading to powerful tools to help scientists better understand diseases such as muscular dystrophy.



    Skeletal muscle contains a complex array of cell types. Among its principal components are multi-nucleated muscle fibers and muscle satellite cells -- cells located in close association with muscle fibers and containing precursors capable of giving rise to new muscle fibers.

    "Our studies show that only the satellite cells, located near muscle fibers, can give rise to new muscle cells. Contrary to previous studies, precursor cells from bone marrow or other blood-forming tissues did not change their destiny to become muscle cells," said Amy J. Wagers, Ph.D., Investigator in the Developmental and Stem Cell Biology Research Section at Joslin Diabetes Center and Assistant Professor of Pathology at Harvard Medical School, the principal investigator of a study published in the Nov. 12 edition of Cell. The research, which originated in the laboratory of Irving L. Weissman, M.D., at Stanford University, now continues at Joslin Diabetes Center in Boston. Over the past few years, several research groups have reported that stem cells found in the bone marrow could repair damaged muscle cells. This had raised hopes that the well-characterized blood-forming stem cells could be used therapeutically to treat muscular diseases. Dr. Wagers' work disputes these past results, showing that bone marrow stem cells do move to the muscle but don't regularly participate in repairing muscle damage.

    In the first part of the Dr. Wagers' latest study, the researchers isolated muscle satellite cells from mice and marked them with a substance that glows in fluorescent light. They also generated adult bone-marrow cells and blood-forming stem cells that carried the fluorescent markers. They then examined the capacity of these three different cell types to generate new muscle cells in cell culture or in mice that had injured muscle tissue.

    "The results show that adult stem cells that are committed to the blood lineage do not normally differentiate into muscle cells," said Dr. Wagers. "The only cells that had full potential to generate muscle cells were derived from muscle, not from transplanted bone-marrow or blood-forming stem cells."

    Armed with this information, the researchers looked for the exact cells involved. To do this, they developed a new method that uses a set of unique cell-surface markers. This method allowed them to isolate and distinguish a subset of muscle precursor cells that give rise, at high frequency, to new muscle cells.

    They found a precise cell type -- the precursor to new muscle growth. In fact, a single cell from this subset could alone generate a sizable colony of new muscle cells.

    "Identifying this precursor of new muscle cells gives us new research tools for future studies, including those in humans," said Dr. Wagers. "As we learn more about the genes expressed by these cells and the pathways involved in regulating them, we can learn more about muscle cell injury and regeneration. This may give us a better understanding of what goes wrong in degenerative diseases such as muscular dystrophy, leading possibly to new ways to treat such diseases."

    The Research Team

    This research initiative, which originated at Stanford University, is now underway at Joslin Diabetes Center in the laboratory of Dr. Wagers. The study's first author was Richard I. Sherwood, currently a graduate student in the Department of Molecular and Cellular Biology at Harvard University. Other investigators included Julie L. Christensen, Ph.D., currently at Cellerant Therapeutics; Irina M. Conboy, Ph.D., an Assistant Professor in the Department of Bioengineering at University of California-Berkeley; Michael J. Conboy, Ph.D., a postdoctoral fellow at Stanford University; Thomas A. Rando, M.D., Ph.D., Associate Professor of Neurology and Neurological Sciences at Stanford; and Irving L. Weissman, M.D., Professor of Pathology and Developmental Biology at Stanford. Funding for this study was provided in part through grants from the National Institutes of Health, the Department of Veterans Affairs, and the Burroughs Wellcome Fund.

    ###

    Contact: Marjorie Dwyer
    marjorie.dwyer@joslin.harvard.edu
    617-732-2415
    Joslin Diabetes Center


    News Home
    More Cell Biology News


    New Tech Alerts Special Offer Alerts


    Receive e-mail alerts on the latest technologies in:
    Sign-up to find out about special offers on products:



    Apoptosis
    Cell Biology & Tissue Culture
    PCR/RT-PCR
    Electrophoresis
    Nucleic Acid Purification
    Transfection
    Laboratory Equipment
    Immunochemicals
    Software
    Cloning
    Protein Biochemistry
    Bio-Services
    Imaging Systems
    Molecular Biology

    Your Email Address:



    HTML-Formatted
    Text-Only

    Tissue Culture
    Array Technology
    PCR
    Cloning
    Signal Transduction
    Antibodies
    Nucelic Acid Isolation
    Imaging/Microscopy
    Laboratory Equipment
    Transfection
    Protein Expression
    Flow Cytometry
    Robotics/Automation

    Your Email Address:



    HTML-Formatted
    Text-Only


    News Sections


    Breaking News
    Patent News
    Clinical Trial News
    Discipline

    Cancer
    Cell Biology
    Drug Discovery
    Genomics
    Immunology
    Industry News
    Infectious Disease
    Life Science
    Mass Spectrometry
    Molecular Biology
    Neuroscience
    Product News
    Proteomics

    New Technologies


    Veritasâ„¢ Microplate Luminometer
    Turner BioSystems

    More Info

    Human/Mouse Active HIF-1α DuoSet® IC ELISA
    R&D Systems

    More Info

    More New Technologies

    Newsletters

    Stay up to date on the latest technologies and science news.

    Life Science
    Molecular Biology
    Immunology
    Neuroscience
    Cancer
    Cell Biology
    Infectious Disease
    Genomics
    Drug Discovery
    Industry News
    Clinical Trials
    Patent News
    Proteomics

    Your email address:


    HTML-Formatted
    Text-Only




    11/12/2004

    Source: Joslin Diabetes Center



    Scientists at Stanford University and Joslin Diabetes Center are providing new insights into how muscle cells regenerate -- leading to powerful tools to help scientists better understand diseases such as muscular dystrophy.



    Skeletal muscle contains a complex array of cell types. Among its principal components are multi-nucleated muscle fibers and muscle satellite cells -- cells located in close association with muscle fibers and containing precursors capable of giving rise to new muscle fibers.

    "Our studies show that only the satellite cells, located near muscle fibers, can give rise to new muscle cells. Contrary to previous studies, precursor cells from bone marrow or other blood-forming tissues did not change their destiny to become muscle cells," said Amy J. Wagers, Ph.D., Investigator in the Developmental and Stem Cell Biology Research Section at Joslin Diabetes Center and Assistant Professor of Pathology at Harvard Medical School, the principal investigator of a study published in the Nov. 12 edition of Cell. The research, which originated in the laboratory of Irving L. Weissman, M.D., at Stanford University, now continues at Joslin Diabetes Center in Boston. Over the past few years, several research groups have reported that stem cells found in the bone marrow could repair damaged muscle cells. This had raised hopes that the well-characterized blood-forming stem cells could be used therapeutically to treat muscular diseases. Dr. Wagers' work disputes these past results, showing that bone marrow stem cells do move to the muscle but don't regularly participate in repairing muscle damage.

    In the first part of the Dr. Wagers' latest study, the researchers isolated muscle satellite cells from mice and marked them with a substance that glows in fluorescent light. They also generated adult bone-marrow cells and blood-forming stem cells that carried the fluorescent markers. They then examined the capacity of these three different cell types to generate new muscle cells in cell culture or in mice that had injured muscle tissue.

    "The results show that adult stem cells that are committed to the blood lineage do not normally differentiate into muscle cells," said Dr. Wagers. "The only cells that had full potential to generate muscle cells were derived from muscle, not from transplanted bone-marrow or blood-forming stem cells."

    Armed with this information, the researchers looked for the exact cells involved. To do this, they developed a new method that uses a set of unique cell-surface markers. This method allowed them to isolate and distinguish a subset of muscle precursor cells that give rise, at high frequency, to new muscle cells.

    They found a precise cell type -- the precursor to new muscle growth. In fact, a single cell from this subset could alone generate a sizable colony of new muscle cells.

    "Identifying this precursor of new muscle cells gives us new research tools for future studies, including those in humans," said Dr. Wagers. "As we learn more about the genes expressed by these cells and the pathways involved in regulating them, we can learn more about muscle cell injury and regeneration. This may give us a better understanding of what goes wrong in degenerative diseases such as muscular dystrophy, leading possibly to new ways to treat such diseases."

    The Research Team

    This research initiative, which originated at Stanford University, is now underway at Joslin Diabetes Center in the laboratory of Dr. Wagers. The study's first author was Richard I. Sherwood, currently a graduate student in the Department of Molecular and Cellular Biology at Harvard University. Other investigators included Julie L. Christensen, Ph.D., currently at Cellerant Therapeutics; Irina M. Conboy, Ph.D., an Assistant Professor in the Department of Bioengineering at University of California-Berkeley; Michael J. Conboy, Ph.D., a postdoctoral fellow at Stanford University; Thomas A. Rando, M.D., Ph.D., Associate Professor of Neurology and Neurological Sciences at Stanford; and Irving L. Weissman, M.D., Professor of Pathology and Developmental Biology at Stanford. Funding for this study was provided in part through grants from the National Institutes of Health, the Department of Veterans Affairs, and the Burroughs Wellcome Fund.

    ###

    Contact: Marjorie Dwyer
    marjorie.dwyer@joslin.harvard.edu
    617-732-2415
    Joslin Diabetes Center


    News Home
    More Cell Biology News


    New Tech Alerts Special Offer Alerts


    Receive e-mail alerts on the latest technologies in:
    Sign-up to find out about special offers on products:



    Apoptosis
    Cell Biology & Tissue Culture
    PCR/RT-PCR
    Electrophoresis
    Nucleic Acid Purification
    Transfection
    Laboratory Equipment
    Immunochemicals
    Software
    Cloning
    Protein Biochemistry
    Bio-Services
    Imaging Systems
    Molecular Biology

    Your Email Address:



    HTML-Formatted
    Text-Only

    Tissue Culture
    Array Technology
    PCR
    Cloning
    Signal Transduction
    Antibodies
    Nucelic Acid Isolation
    Imaging/Microscopy
    Laboratory Equipment
    Transfection
    Protein Expression
    Flow Cytometry
    Robotics/Automation

    Your Email Address:



    HTML-Formatted
    Text-Only


    News Sections


    Breaking News
    Patent News
    Clinical Trial News
    Discipline

    Cancer
    Cell Biology
    Drug Discovery
    Genomics
    Immunology
    Industry News
    Infectious Disease
    Life Science
    Mass Spectrometry
    Molecular Biology
    Neuroscience
    Product News
    Proteomics

    New Technologies


    Veritasâ„¢ Microplate Luminometer
    Turner BioSystems

    More Info

    Human/Mouse Active HIF-1α DuoSet® IC ELISA
    R&D Systems

    More Info

    More New Technologies

    Newsletters

    Stay up to date on the latest technologies and science news.

    Life Science
    Molecular Biology
    Immunology
    Neuroscience
    Cancer
    Cell Biology
    Infectious Disease
    Genomics
    Drug Discovery
    Industry News
    Clinical Trials
    Patent News
    Proteomics

    Your email address:


    HTML-Formatted
    Text-Only

  2. #2
    Senior Member
    Join Date
    Mar 2003
    Location
    Copper Canyon, Texas
    Posts
    377
    Thanks Dr. JJ,
    Maybe not what we want to hear, but important feedback!

    "The results show that adult stem cells that are committed to the blood lineage do not normally differentiate into muscle cells," said Dr. Wagers. "The only cells that had full potential to generate muscle cells were derived from muscle, not from transplanted bone-marrow or blood-forming stem cells."

    Armed with this information, the researchers looked for the exact cells involved. To do this, they developed a new method that uses a set of unique cell-surface markers. This method allowed them to isolate and distinguish a subset of muscle precursor cells that give rise, at high frequency, to new muscle cells.

    They found a precise cell type -- the precursor to new muscle growth. In fact, a single cell from this subset could alone generate a sizable colony of new muscle cells.

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •